Bone density and markers of bone remodeling in type 1 male diabetic patients.

Abstract:

AIMS:To assess the prevalence and severity of bone disease in type 1 diabetic patients and to determine serum markers of bone remodeling as well as their relationship with bone mineral density (BMD). METHODS:BMD [by dual energy x-ray absorptiometry (DXA)] and serum markers of bone remodeling [osteocalcin, c-terminal telopeptide of type I collagen (CTX)], leptin and osteoprotegerin (OPG) were measured in 42 adult males with type 1 diabetes. Twenty-four non-diabetic subjects served as controls. RESULTS:In 40% of the patients, osteopenia at the lumbar spine (L1-L4) and/or at the left hip was found, and 7% met criteria for osteoporosis. L1-L4 BMD z-score was correlated with age (r=0.365, P=0.018) and a similar trend was observed at left hip. L1-L4 BMD z-score was negatively correlated with CTX and osteocalcin (r=-0.343, P=0.028; r=-0.376, P=0.024, respectively). A significant correlation was evidenced between BMD z-score at both lumbar spine and left hip and leptin values (r=0.343, P=0.03; r=0.395, P=0.012, respectively) but after adjustment for weight this correlation was no longer significant. Osteocalcin, CTX and leptin concentrations were comparable between patients and controls, while OPG concentrations tend to be higher in diabetic subjects (P=0.08). CTX was negatively correlated with age (r=-0.390, P=0.012) and positively correlated with osteocalcin (r=0.696, P<0.001). OPG was positively correlated with age (r=0.507, P=0.001). CONCLUSION:Our results suggest that in diabetic subjects osteopenia is a relatively frequent complication but bone loss is attenuated with age progression. Whether this is also mediated by OPG and/or leptin remains to be confirmed.

journal_name

Diabetes Metab

journal_title

Diabetes & metabolism

authors

Alexopoulou O,Jamart J,Devogelaer JP,Brichard S,de Nayer P,Buysschaert M

doi

10.1016/s1262-3636(07)70303-8

subject

Has Abstract

pub_date

2006-11-01 00:00:00

pages

453-8

issue

5 Pt 1

eissn

1262-3636

issn

1878-1780

pii

s1262-3636(07)70303-8

journal_volume

32

pub_type

杂志文章
  • Role of fatty liver in the association between obesity and reduced hepatic insulin clearance.

    abstract:AIM:Hepatic insulin clearance (HIC) is important in regulating plasma insulin levels. Diminished HIC causes inappropriate hyperinsulinaemia, and both obesity and fatty liver (FL), which are known to decrease HIC, can be found either together in the same patient or on their own. The mechanism by which obesity reduces HI...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2017.12.003

    authors: Matsubayashi Y,Yoshida A,Suganami H,Ishiguro H,Yamamoto M,Fujihara K,Kodama S,Tanaka S,Kaku K,Sone H

    更新日期:2018-03-01 00:00:00

  • Association between metabolically unhealthy overweight/obesity and chronic kidney disease: the role of inflammation.

    abstract:AIM:Our study explored the association between subtypes of increased fat mass (with or without associated metabolic alterations) and the presence of chronic kidney disease (CKD). METHODS:In this cross-sectional survey in China, body mass index (BMI) was used to assess fat mass. Metabolically healthy was defined as no ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2014.08.005

    authors: Chen S,Zhou S,Wu B,Zhao Y,Liu X,Liang Y,Shao X,Holthöfer H,Zou H

    更新日期:2014-12-01 00:00:00

  • Polymorphism of stress protein HSP70-2 gene in Tunisians: susceptibility implications in type 2 diabetes and obesity.

    abstract:OBJECTIVES:Tumor necrosis factor alpha (TNFalpha) is expressed primarily in adipocytes and elevated levels of this cytokine have been linked to obesity and insulin resistance. Several studies have shown statistical evidence of linkage between obesity and the chromosomal region encompassing the TNFalpha gene, suggesting...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70104-0

    authors: Zouari Bouassida K,Chouchane L,Jellouli K,Chérif S,Haddad S,Gabbouj S,Danguir J

    更新日期:2004-04-01 00:00:00

  • Alternatives routes of insulin delivery.

    abstract::Optimal glycaemic control is necessary to prevent diabetes-related complications. An intensive treatment, which could mimic physiological insulin secretion, would be the best one. However subcutaneous insulin treatment is not physiologic and represents a heavy burden for patients with type 1 and type 2 diabetes mellit...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/s1262-3636(06)72804-x

    authors: Lassmann-Vague V,Raccah D

    更新日期:2006-12-01 00:00:00

  • Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial.

    abstract:AIM:Albuminuria is the most important indicator of diabetic nephropathy (DN). Resveratrol, a natural compound found in grape skins and red wine, has antioxidant effects. This study aimed to evaluate the effects of resveratrol on DN. METHODS:In this randomized, double-blind, placebo-controlled clinical trial, 60 patien...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.diabet.2018.05.010

    authors: Sattarinezhad A,Roozbeh J,Shirazi Yeganeh B,Omrani GR,Shams M

    更新日期:2019-01-01 00:00:00

  • Individualizing treatment of type 2 diabetes by targeting postprandial or fasting hyperglycaemia: Response to a basal vs a premixed insulin regimen by HbA1c quartiles and ethnicity.

    abstract:AIM:This study evaluated the proportions of prandial (PHG) vs fasting hyperglycaemia (FHG) over 24h in a group of patients with type 2 diabetes (overall and for Caucasian vs Asian patients), and tested the hypothesis that an insulin regimen with a prandial component allows a greater response than basal insulin at low g...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.diabet.2015.03.002

    authors: Scheen AJ,Schmitt H,Jiang HH,Ivanyi T

    更新日期:2015-06-01 00:00:00

  • [Molecular mechanisms of insulin secretion].

    abstract::Insulin secretion from the beta-cells in the islets of Langerhans is mainly regulated by glucose entry via its transporter. The intracellular glucose metabolism induces a rise in ATP/ADP ratio which increases the degree of closure of ATP-sensitive potassium channels (K(ATP) channels), inducing a higher intracellular K...

    journal_title:Diabetes & metabolism

    pub_type: 评论,杂志文章,评审

    doi:

    authors: Bataille D

    更新日期:2002-12-01 00:00:00

  • Impact of elective hospital admissions on glycaemic control in adolescents with poorly controlled type 1 diabetes.

    abstract:AIM:Different treatment strategies have been used to manage adolescents with poorly controlled type 1 diabetes. We investigated whether a brief elective hospital admission improves haemoglobin A(1c) (HbA(1c)) over 12 months. METHODS:We studied a retrospective cohort of adolescents with poorly controlled type 1 diabete...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2013.04.003

    authors: Millette M,Mok E,Legault L

    更新日期:2013-12-01 00:00:00

  • Insulin secretion, peripheral insulin sensitivity and insulin-receptor binding in subjects with different degrees of obesity.

    abstract:OBJECTIVES:The aim of the present study was to investigate insulin secretion, insulin-receptor binding and peripheral insulin sensitivity in subjects with different degrees of obesity. METHODS:36 obese subjects with normal glucose tolerance and different degrees of obesity and 40 healthy normal-weight subjects partici...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70138-6

    authors: Borissova AM,Tankova TI,Koev DJ

    更新日期:2004-11-01 00:00:00

  • Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.

    abstract::In Type 1 diabetes, high circulating growth hormone (GH) in conjunction with low plasma insulin-like growth factor-I (IGF-I) is indicative of a hepatic GH-resistance profile since the liver is the main source of circulating IGF-I. The reduction in specific growth hormone binding protein (GHBP), corresponding to the ex...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Hanaire-Broutin H,Sallerin-Caute B,Poncet MF,Tauber M,Bastide R,Rosenfeld R,Tauber JP

    更新日期:1996-07-01 00:00:00

  • Growth factors and diabetic retinopathy.

    abstract::Preretinal neovascularization and chronic retinal oedema are the two major sight-threatening complications that can occur during diabetic retinopathy. Ocular neovascularization is strongly associated with retinal ischaemia, and growth factors have been implicated in its pathogenesis. The ischaemic retina is assumed to...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Paques M,Massin P,Gaudric A

    更新日期:1997-04-01 00:00:00

  • Balance of substrate oxidation during submaximal exercise in lean and obese people.

    abstract:OBJECTIVES:To compare fat and carbohydrate oxidation at different exercise intensities between overweight and normal-weight subjects, in order to analyze the influence of muscular metabolic abnormalities in obese people on substrate utilization during exercise. MATERIAL AND METHODS:32 healthy sedentary overweight subj...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Pérez-Martin A,Dumortier M,Raynaud E,Brun JF,Fédou C,Bringer J,Mercier J

    更新日期:2001-09-01 00:00:00

  • [Role of bariatric surgery in the obese diabetic].

    abstract::Bariatric surgery can be proposed to address severe obesity associated with comorbid conditions, when medical treatment has failed. Three surgical techniques are currently available, including 2 using coelioscopy. Short term results are encouraging regarding weight loss, which is linked with a reduction in comorbid co...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Simon C

    更新日期:2000-06-01 00:00:00

  • Chromium in the prevention and control of diabetes.

    abstract::Chromium is an essential nutrient involved in the metabolism of glucose, insulin and blood lipids. Suboptimal dietary intake of chromium is associated with increased risk factors associated with diabetes and cardiovascular diseases. Within the past five years, chromium has been shown to improve glucose and related var...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Anderson RA

    更新日期:2000-02-01 00:00:00

  • Incidence of insulin-dependent diabetes mellitus in Benghazi, Libya (1991-1995).

    abstract::This report concerns the incidence rate of insulin-dependent diabetes mellitus (IDDM) in the 0-14 year age group in Benghazi, Libya. Incidence data are based on prospective registration of patients as part of the WHO Diamond Project from 1991 to 1995. A total of 126 IDDM incident cases (73 girls, 53 boys) were identif...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Kadiki OA,Roaeid RB,Bhairi AM,Elamari IM

    更新日期:1998-11-01 00:00:00

  • Adiponectin: an update.

    abstract::The discoveries of leptin and adiponectin were breakthroughs in the field of metabolic diseases. Adipose cells produce both proteins and release them into the circulation. Leptin acts as a fundamental signal for the brain to modulate food intake as a function of energy status. Loss of leptin function results in obesit...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2007.08.002

    authors: Guerre-Millo M

    更新日期:2008-02-01 00:00:00

  • Trends from 1995 to 2006 in the prevalence of self-reported cardiovascular risk factors among elderly Spanish diabetics.

    abstract:AIM:In this study, we examined the trends from 1995 to 2006 in cardiovascular risk factors (CVRF) in Spaniards aged 65 years or older with diabetes. METHODS:We looked at the individual data from adults aged > or =65 years from the Spanish National Health Surveys of 1995 (n=1117), 1997 (n=1111), 2001 (n=4328), 2003 (n=...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2009.06.007

    authors: Jiménez Trujillo I,Jiménez García R,Vazquez-Fernandez del Pozo S,Hernández Barrera V,Carrasco Garrido P,Suarez P,Gil de Miguel A

    更新日期:2010-02-01 00:00:00

  • Determination of HbA1c concentrations in patients with acute myocardial infarction: comparison of the DCA 2000 device with the HPLC method.

    abstract:BACKGROUND:Recent studies suggest that HbA1c is an important predictor of the glycometabolic state of patients admitted for acute myocardial infarction (AMI). OBJECTIVE:We aimed at comparing the results of HbA1c concentrations obtained by 2 different methods in patients with AMI. RESEARCH DESIGN AND METHODS:In a firs...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70196-9

    authors: Hadjadj S,Duengler F,Barriere M,Mauco G,Coisne D,Warnier F,Sosner P,Torremocha F,Herpin D,Marechaud R

    更新日期:2005-06-01 00:00:00

  • HBA1c: clinical and biological agreement for standardization of assay methods. Report by the experts of ALFEDIAM (Association de Langue Française pour lEtude du Diabète et des Maladies Métabolique) and SFBC (Société Française de Biologie Clinique).

    abstract::Glycohaemoglobin, and particularly haemoglobin A1c(HbA1c), assays have been used for many years to retrospectively evaluate the glycaemic control of diabetic patients. Cut-off values have been established for deciding treatment modifications. The techniques used in the laboratories however exhibit varying quality, and...

    journal_title:Diabetes & metabolism

    pub_type: 指南,杂志文章

    doi:

    authors: Gillery P,Bordas-Fonfrède M,Chapelle JP,Drouin P,Hue G,Lévy-Marchal C,Périer C,Sélam JL,Slama G,Thivolet C,Vialettes B

    更新日期:1999-09-01 00:00:00

  • Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.

    abstract:OBJECTIVE:To determine the relationship between CRP levels and the components of MS in normal glucose tolerant (NGT), impaired glucose tolerant (IGT), and Type 2 diabetic subjects. MATERIAL AND METHODS:A based cross-sectional population study was performed. Eligible subjects, men and non-pregnant women, 30 to 64 year ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70009-5

    authors: Guerrero-Romero F,Rodríguez-Morán M

    更新日期:2003-02-01 00:00:00

  • Hypoglycaemic episodes in patients with type 2 diabetes--risk factors and associations with patient-reported outcomes: The PANORAMA Study.

    abstract:AIM:To explore the frequency of hypoglycaemic episodes, their risk factors, and associations with patient-reported outcomes in patients with type 2 diabetes enrolled in the PANORAMA cross-sectional study. METHODS:Five thousand seven hundred and eighty-three patients aged ≥ 40 years with type 2 diabetes duration ≥ 1 ye...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2015.08.007

    authors: Simon D,de Pablos-Velasco P,Parhofer KG,Gönder-Frederick L,Duprat Lomon I,Vandenberghe H,Eschwège E,Bradley C

    更新日期:2015-12-01 00:00:00

  • Propranolol in hypoglycaemia unawareness.

    abstract::The effect of propranolol on the occurrence of hypoglycaemic symptoms was assessed in insulin-dependent diabetic patients with hypoglycaemia unawareness. A double-blind, randomised parallel group study (2:1 fashion) was conducted over 4-week period. The propranolol group (n = 9) received 20 mg (week 1 and 2) and 30 mg...

    journal_title:Diabetes & metabolism

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Chalon S,Berlin I,Sachon C,Bosquet F,Grimaldi A

    更新日期:1999-03-01 00:00:00

  • Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis.

    abstract:AIM:To evaluate the correspondence between first-trimester fasting glycaemia and the results of the OGTT in diagnosing gestational diabetes (GDM). METHODS:The medical records of all consecutive women who had undergone a diagnostic OGTT, performed according to the IADPSG, during the past year were retrospectively revie...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2012.03.006

    authors: Corrado F,D'Anna R,Cannata ML,Interdonato ML,Pintaudi B,Di Benedetto A

    更新日期:2012-11-01 00:00:00

  • Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).

    abstract:OBJECTIVE:To determine the utility of the continuous glucose monitoring system (CGMS) as an outpatient procedure to improve management of diabetes in adolescents. RESEARCH DESIGN AND METHODS:Twelve adolescents (mean age: 16.2 +/- 3 years) with poorly controlled type 1 diabetes (HbA(1c) > 8%) were included in this tria...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70076-9

    authors: Schaepelynck-Bélicar P,Vague P,Simonin G,Lassmann-Vague V

    更新日期:2003-12-01 00:00:00

  • Factors related to CSII compliance.

    abstract::Many studies have demonstrated the metabolic efficacy of continuous subcutaneous insulin infusion (CSII) and particularly a reduction of glycaemic fluctuations in type 1 diabetic patients. Despite this benefit, many patients decide to discontinue the use of CSII. To determine the factors related to discontinuation of ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70173-8

    authors: Ronsin O,Jannot-Lamotte MF,Vague P,Lassman-Vague V

    更新日期:2005-02-01 00:00:00

  • Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study.

    abstract:AIMS:Reactive dicarbonyl compounds, such as methylglyoxal (MGO), rise during an oral glucose tolerance test (OGTT), particularly in (pre)diabetes. Fasting MGO levels are associated with chronic kidney disease (CKD) and cardiovascular disease (CVD) in patients with poorly controlled type 2 diabetes mellitus (T2DM). Yet,...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2020.02.002

    authors: Hanssen NMJ,Scheijen JLJM,Houben AJHM,van de Waarenburg M,Berendschot TTJM,Webers CAB,Reesink KD,van Greevenbroek MMJ,van der Kallen C,Schaper NC,Schram MT,Henry RMA,Stehouwer CDA,Schalkwijk CG

    更新日期:2020-02-10 00:00:00

  • The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study.

    abstract:CONTEXT:In 2001 the "National Cholesterol and Education Program Expert Panel" gave a clinical definition of the metabolic syndrome. The frequency of this syndrome at baseline and its incidence and persistence at three years is studied in a French population. SUBJECTS:2109 men and 2184 women from the D.E.S.I.R. longitu...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70067-8

    authors: Balkau B,Vernay M,Mhamdi L,Novak M,Arondel D,Vol S,Tichet J,Eschwège E,D.E.S.I.R. Study Group.

    更新日期:2003-11-01 00:00:00

  • Effect of canagliflozin on liver function tests in patients with type 2 diabetes.

    abstract:AIMS:To report changes in liver function tests observed with canagliflozin, a sodium glucose co-transporter 2 inhibitor, across phase 3 studies in patients with type 2 diabetes, and to examine the relationship between changes in liver function tests and the weight loss and glycaemic improvements observed with canaglifl...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.diabet.2015.10.003

    authors: Leiter LA,Forst T,Polidori D,Balis DA,Xie J,Sha S

    更新日期:2016-02-01 00:00:00

  • [From external to implantable insulin pump, can we close the loop?].

    abstract::The project to finalize a 'closed loop' insulin delivery according to blood glucose level, i.e. an implanted artificial beta cell, is born from the development of the first miniaturized portable insulin pumps during the 1970s. Continuous improvements in micro-electronics, as well as in the development of biomaterials ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Renard E,Costalat G,Bringer J

    更新日期:2002-09-01 00:00:00

  • Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease.

    abstract::Protease inhibitor treatment has dramatically improved rates of morbidity and mortality in HIV-infected patients. However, it has recently been shown that this medication is associated with long-term side effects characterized by metabolic, clinical and biological alterations. These modifications have been described i...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Vigouroux C,Gharakhanian S,Salhi Y,Nguyên TH,Adda N,Rozenbaum W,Capeau J

    更新日期:1999-11-01 00:00:00